Hera Biotech, Inc.

SAN ANTONIO, TX · Founded 2020 · CIK 0001831293 · Medtech · Private

Tissue-based diagnostic platform for endometriosis and cervical cancer detection

herabiotech.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$1.2M
4 Form D · Sep 2025
13 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$95,000
Private capital raisedForm D · SEC$260,000
Private capital raisedForm D · SEC$6,000,000
Private capital raisedForm D · SEC$796,328
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
973Lumina Diagnostics, Inc.——
974Hard 8 Games, LLC—$1.5M
975THERMEDICAL, INC.—$20M
976Hera Biotech, Inc.—$1.2M
977Mila International Inc.—$2.0M
978AAI Global Institutional LLC-S——
979Nexstim Plc—$3.7M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Somer BaburekDirector · Executive Officer
  • Paul CastellaDirector · Executive Officer
  • Wendy SmithDirector
  • Neal Walsdorf, Jr.Director

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.